[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-515726-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-515726-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","wcg-irb-guide-for-researchers-rev-130-17-jun-2026","WCG IRB Guide for Researchers - Rev 1.30 - 17 Jun 2026","","WCG IRB Guide for Researchers (Rev 1.30, 17 Jun 2026) provides structured guidance for conducting and submitting human-subject research to WCG IRB. It covers exemptions, initial review and required materials, and the regulatory framework supporting IRB functions, including HIPAA. The guide details informed consent goals, process considerations, multilingual consent workflows (including AI-assisted translations), translator use for non-English records, and consent for diverse participant circumstances. It also addresses conflicts of interest, risk considerations, investigator qualifications, board actions, and reporting such as DSUR submissions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/wcg-irb-guide-for-researchers-rev-130-17-jun-2026/515726/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/wcg-irb-guide-for-researchers-rev-130-17-jun-2026/515726.png","ImageObject",300,407,{"name":42,"@type":43},"Putri","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-10","2026-10-06",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",13,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What new guidance is added in Rev 1.30 of the WCG IRB Guide for Researchers?","Question",{"text":63,"@type":64},"Rev 1.30 adds guidance on including HIPAA waiver language in ICFs, identifying site-specific information sections in template consent forms, reviewing non-English medical records with a translator, and sponsor/CRO/site coordinated translations using AI.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the guide address multilingual informed consent and translation support?",{"text":68,"@type":64},"It provides recommendations for reviewing multilingual research, navigating studies intended solely for non-English languages, obtaining consent with limited English literacy, and handling translations with coordinated efforts using AI support and/or translators.",{"name":70,"@type":61,"acceptedAnswer":71},"What topics does the guide cover beyond consent, such as risk and conflicts of interest?",{"text":72,"@type":64},"The guide includes sections on the amount of risk, the effect of conflicts of interest on subjective decision-making, training in conflicts of interest, investigator qualifications, possible board actions, and compensation for research conduct.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},515726,1791427643,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":112,"preview_urls":147},962085571259,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","WCG IRB Guide for Researchers  \nRev 1.30  \n17 Jun 2026  \nRevised in this version:  \n• Add additional guidance about including HIPAA waiver language in ICFs.  \n• Add additional guidance for sponsors and CROs about identifying site-specific information sections in template consent forms.  \n• Add guidance about reviewing non-English medical records using a translator  \n• Add guidance about sponsor/CRO/site coordinated translations using AI  \n• Add guidance about PI’s who are not regular, full time employees of the institution or site.  \n• Add rationale for WCG policy to not include signatures on US Certificates of Action  \n• Add guidance about sending DSUR reports to WCG IRB for review  \n• In this version, references to the Connexus portal have been universally replaced with references to the ClinSphere ® eReview Manager portal – but please note that migration of records from Connexus to eReview Manager is ongoing and users will continue to access their records and make submissions for existing research via Connexus until they receive notification that their records have been migrated to eReview Manager.  \nContents  \nIntroduction ............................................................................................................................ 9  \nWorking with WCG IRB for IRB Review-An Overview....................................................... 9  \nExemptions........................................................................................................................... 10  \nSubmitting Documents for IRB Review.............................................................................. 10  \nMaterials Required for Initial Review.................................................................................. 11  \nItems Required for All Initial Review Requests.................................................................. 11  \nFor Drugs, Biologics, and Food Supplements ................................................................... 11  \nFor Device Studies: ........................................................................................................... 12  \nRegulations Affecting Clinical Research, Including HIPAA: The Regulatory Framework Within Which WCG IRB Functions ..................................................................................... 12  \nResearch Conducted Globally........................................................................................... 13  \nHIPAA ............................................................................................................................... 13  \nConflicts of Interest ............................................................................................................. 13  \nAmount of Risk .................................................................................................................. 15  \nEffect of the Conflict of Interest on Subjective Decision-Making ....................................... 15  \nAmount of Interaction Between the Conflicted Party and the Participants ........................ 15  \nOther Parties Involved in Overseeing the Conflict of Interest ............................................ 15  \nTraining in Conflict of Interest............................................................................................ 15  \nUnique Qualifications ........................................................................................................ 16  \nPossible Board Actions ..................................................................................................... 16  \nCompensation to Investigators and Study Teams for the Conduct of Research ............... 16  \nThe Informed Consent Process .......................................................................................... 17  \nGoals for the Informed Consent Process .......................................................................... 17  \nConsent Process Diagram ..................................................","cbCailS2yMuEaqzj","https://ap.wps.com/l/cbCailS2yMuEaqzj","pdf",932178,76,"English","# Introduction\n## Working with WCG IRB for IRB Review - An Overview\n## Exemptions\n## Submitting Documents for IRB Review\n## Materials Required for Initial Review\n## Items Required for All Initial Review Requests\n## Regulations Affecting Clinical Research, Including HIPAA\n## The Informed Consent Process\n## Waivers of Consent for Non-FDA Studies\n## Waivers of Consent for FDA Studies\n## Waiver of Documentation of Consent","[{\"question\":\"What new guidance is added in Rev 1.30 of the WCG IRB Guide for Researchers?\",\"answer\":\"Rev 1.30 adds guidance on including HIPAA waiver language in ICFs, identifying site-specific information sections in template consent forms, reviewing non-English medical records with a translator, and sponsor/CRO/site coordinated translations using AI.\"},{\"question\":\"How does the guide address multilingual informed consent and translation support?\",\"answer\":\"It provides recommendations for reviewing multilingual research, navigating studies intended solely for non-English languages, obtaining consent with limited English literacy, and handling translations with coordinated efforts using AI support and/or translators.\"},{\"question\":\"What topics does the guide cover beyond consent, such as risk and conflicts of interest?\",\"answer\":\"The guide includes sections on the amount of risk, the effect of conflicts of interest on subjective decision-making, training in conflicts of interest, investigator qualifications, possible board actions, and compensation for research conduct.\"}]","WCG IRB Guide for Researchers - Rev 1.30 - 17 Jun 2026 | PDF",1791321607,192,[148,152,156,160,164,168,172,176],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/bea1ebcc78ee0c386e5a2f3438e60028.webp",983,1272,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/ea243dfda4fafeb79541b2213594a656.webp",982,1270,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/bbc6f0f537d23bad5254e717b0179e7f.webp",981,1269,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/f1e8a3e324c6f15ff83d4ca920361447.webp",980,1268,{"page_no":97,"url":165,"width":166,"height":167},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/27f6a59a3b1a280adcc27166509fa750.webp",979,1267,{"page_no":102,"url":169,"width":170,"height":171},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/dbcd843aaac5db459ae0bf6924d28ff4.webp",978,1265,{"page_no":107,"url":173,"width":174,"height":175},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/9dbe0676287b2c9b103382e2396622b4.webp",977,1264,{"page_no":112,"url":177,"width":178,"height":179},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-17/c9a05e414853a30418edd6428780db66.webp",976,1263]